Xenon Pharmaceuticals (XENE) Non Operating Investment Income (2021 - 2022)
Xenon Pharmaceuticals' (XENE) quarterly Non Operating Investment Income came in at -$1.3 million in Q2 2022, down 7476.47% year-on-year from $17460.9 in Q2 2021, and up 61.69% on a QoQ basis from -$3.4 million in Q1 2022.
Xenon Pharmaceuticals (XENE) Non Operating Investment Income (2021 - 2022) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 2 years of Non Operating Investment Income data on file, last reported at -$1.3 million in Q2 2022.
- On a quarterly basis, Non Operating Investment Income fell 7476.47% year-over-year to -$1.3 million in Q2 2022; TTM through Jun 2022 was -$4.7 million, a N/A change from a year earlier, with the FY2021 full-year figure at -$719000.0, down 18075.0% from the prior year.
- Non Operating Investment Income for Q2 2022 stood at -$1.3 million, up from -$3.4 million in the prior quarter.
- Over the last five years, Non Operating Investment Income for XENE reached as high as -$17000.0 in Q2 2021 and fell as low as -$3.4 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 5.75 Bn | 5.75 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -1.29 Mn |
| Jun 30, 2022 | -1.29 Mn |
| Mar 31, 2022 | -3.36 Mn |
| Mar 31, 2022 | -3.36 Mn |
| Jun 30, 2021 | -17,000.00 |
| Jun 30, 2021 | -17,000.00 |
| Mar 31, 2021 | -74,000.00 |
| Mar 31, 2021 | -74,000.00 |